NCBI PubMed Centralopen access
Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.
machine learning systems
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 666100
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.